Literature DB >> 33675013

Feasibility and acceptability of home-based strength training in endometrial cancer survivors.

Jessica Gorzelitz1, Erin Costanzo2, Ronald Gangnon3,4, Kelli Koltyn1, Amy Trentham Dietz4, Ryan J Spencer5, Joanne Rash5, Lisa Cadmus-Bertram6.   

Abstract

PURPOSE: Physical activity is important for healthy cancer survivorship, yet many endometrial cancer survivors do not participate in recommended muscle-strengthening activity. The purpose of this study was to determine the feasibility of home-based muscle strengthening activity in endometrial cancer survivors.
METHODS: Forty post-treatment endometrial cancer survivors were enrolled in a randomized trial, of twice-weekly home-based strength exercise versus wait-list control. The intervention included educational materials, exercise equipment (dumbbells, resistance bands), and support/feedback via video coaching sessions. Participants completed the exercises twice per week for 10 weeks, with a 5-week follow-up period. Feasibility was measured by program adherence, as well as safety of and satisfaction with the study.
RESULTS: On average, participants were 60.9 years old (SD = 8.7), had a BMI of 39.9 kg/m2 (SD = 15.2), and were 2.9 years (SD = 1.2) since diagnosis. The majority (83%) had stage I disease at diagnosis. Seventy-five percent adhered to the exercise prescription of twice/week, with 85% of participants missing fewer than 3 of the workouts. Forty percent of participants continued workouts during the 5-week follow-up. Participants were highly satisfied with intervention. No injuries or adverse everts occurred.
CONCLUSION: This home-based program was feasible in endometrial cancer survivors. While adherence was measured, future research should focus on long-term maintenance of exercise and should explore progressions and modifications of exercises at a distance for various abilities. IMPLICATIONS FOR CANCER SURVIVORS: Muscle strengthening activities are recommended for all cancer survivors. This study shows that a home-based muscle strengthening exercise is feasible in endometrial cancer survivors.

Entities:  

Keywords:  Endometrial cancer; Exercise; Home based; Muscle; Strength; Survivorship

Year:  2021        PMID: 33675013      PMCID: PMC9362896          DOI: 10.1007/s11764-021-00990-3

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.062


  39 in total

1.  Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study.

Authors:  Morten Quist; Mikael Rørth; Seppo Langer; Lee W Jones; Jørgen H Laursen; Helle Pappot; Karl Bang Christensen; Lis Adamsen
Journal:  Lung Cancer       Date:  2011-08-03       Impact factor: 5.705

2.  USA endometrial cancer projections to 2030: should we be concerned?

Authors:  M Aamir Sheikh; Andrew D Althouse; Kyle E Freese; Sean Soisson; Robert P Edwards; Sharon Welburn; Paniti Sukumvanich; John Comerci; Joseph Kelley; Ronald E LaPorte; Faina Linkov
Journal:  Future Oncol       Date:  2014-12       Impact factor: 3.404

3.  Altered Sexuality and Body Image after Gynecological Cancer Treatment: How Can Psychologists Help?

Authors:  Rebecca Caldwell Sacerdoti; Luciana Lagana'; Cheryl Koopman
Journal:  Prof Psychol Res Pr       Date:  2010-12

4.  Cardiovascular disease is the leading cause of death among endometrial cancer patients.

Authors:  Kristy K Ward; Nina R Shah; Cheryl C Saenz; Michael T McHale; Edwin A Alvarez; Steven C Plaxe
Journal:  Gynecol Oncol       Date:  2012-04-13       Impact factor: 5.482

5.  Physical Activity in Cancer Prevention and Survival: A Systematic Review.

Authors:  Anne McTiernan; Christine M Friedenreich; Peter T Katzmarzyk; Kenneth E Powell; Richard Macko; David Buchner; Linda S Pescatello; Bonny Bloodgood; Bethany Tennant; Alison Vaux-Bjerke; Stephanie M George; Richard P Troiano; Katrina L Piercy
Journal:  Med Sci Sports Exerc       Date:  2019-06       Impact factor: 5.411

Review 6.  Disparities in breast cancer stage at diagnosis in urban and rural adult women: a systematic review and meta-analysis.

Authors:  Sallyanne Nguyen-Pham; Janni Leung; Deirdre McLaughlin
Journal:  Ann Epidemiol       Date:  2013-12-28       Impact factor: 3.797

7.  Physical activity for an ethnically diverse sample of endometrial cancer survivors: a needs assessment and pilot intervention.

Authors:  Amerigo Rossi; Alyson Moadel-Robblee; Carol Ewing Garber; Dennis Kuo; Gary Goldberg; Mark Einstein; Nicole Nevadunsky
Journal:  J Gynecol Oncol       Date:  2015-04       Impact factor: 4.401

8.  Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial.

Authors:  Camilla K Lonkvist; Simon Lønbro; Anders Vinther; Bo Zerahn; Eva Rosenbom; Hanne Primdahl; Pernille Hojman; Julie Gehl
Journal:  BMC Cancer       Date:  2017-06-03       Impact factor: 4.430

9.  Community-based exercise for health promotion and secondary cancer prevention in Canada: protocol for a hybrid effectiveness-implementation study.

Authors:  Margaret L McNeely; Christopher Sellar; Tanya Williamson; Melissa Shea-Budgell; Anil Abraham Joy; Harold Y Lau; Jacob C Easaw; Albert D Murtha; Jeffrey Vallance; Kerry Courneya; John R Mackey; Matthew Parliament; Nicole Culos-Reed
Journal:  BMJ Open       Date:  2019-09-13       Impact factor: 2.692

10.  Exercise Programme in Endometrial Cancer; Protocol of the Feasibility and Acceptability Survivorship Trial (EPEC-FAST).

Authors:  Anke Smits; Alberto Lopes; Nagindra Das; Ruud Bekkers; Leon Massuger; Khadra Galaal
Journal:  BMJ Open       Date:  2015-12-16       Impact factor: 2.692

View more
  1 in total

1.  Improvements in strength and agility measures of functional fitness following a telehealth-delivered home-based exercise intervention in endometrial cancer survivors.

Authors:  Jessica S Gorzelitz; Stefanie Stoller; Erin Costanzo; Ronald Gangnon; Kelli Koltyn; Amy Trentham Dietz; Ryan J Spencer; Joanne Rash; Lisa Cadmus-Bertram
Journal:  Support Care Cancer       Date:  2021-07-25       Impact factor: 3.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.